(84 days)
Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: Fetal, Abdominal, Pediatric, Small Organ (Thyroid, Breast and Testicles), Neonatal Cephalic, Adult Cephalic, Cardiac, Transesophageal, Transrectal, Transvaginal, Peripheral Vascular.
ESAOTE's Mod. 7250 is a compact ultrasound system used to perform non-invasive diagnostic general ultrasound studies. Its primary modes of operation are the following: B-Mode, M-Mode, Doppler, Color Flow Mapping and Amplitude Doppler, The MOD.7250 can be equipped with an LCD Color Display (Portable Configuration) or with a 15" Color Monitor and a cart (Mainframe Configuration). The full alphanumeric keyboard allows complete on-screen data entry of patient information and on-screen annotations.
The MOD. 7250 can drive annular array, phased, convex and linear array probes. In addition. Mod.7250 is equipped with a volumetric scan converter and the ability to control simultaneously two independent scan planes. This technological characteristic allows to manage Bi-Scan Probes, to obtain volumetric datasets; these datasets can then be used to display "omni-directional" 2D images (anyplane sectioning) as well as multiple parallel equidistant sections (paraplane sectioning). This Bi-Scan approach is ideal for volume computations through the Simoson rule: specifically, it can be used to measure volumes of irregular structures since it does not reguire a geometrical assumption.
The MOD.7250 is designed for ease of use. The user interface allows the operator to perform an examination quickly and efficiently. Clearly labeled mode selection keys are easily accessed, and the system's "pop-up" menus allow the operator to change parameters with ease. The user may also access special function menus and perform calculations with a minimal number of key strokes. The MOD.7250 offers a vast selection of calculations and measurements which can be performed quickly and easily. The MOD.7250 is equipped with a 3.5" floppy disk drive to simplify software modifications and provides fast, cost effective system upgrades. This drive (or an optional Optical Disk Drive) can also be used for image storage. Moreover, this unit can store data directly to a Personal Computer via a LAN (Network) port. In addition, MOD.7250 can be equipped with recording devices, including a S-VHS video recorder and a black-and-white or color page printer, which are controlled through the keyboard.
The provided text describes the "7250 Ultrasound Imaging System" by Biosound Esaote. This document is a Summary of Safety and Effectiveness for a 510(k) premarket notification to the FDA, issued in 1998.
Acceptance Criteria and Study for the 7250 Ultrasound Imaging System:
The acceptance criteria for the 7250 Ultrasound Imaging System are implicitly defined by its substantial equivalence to a predicate device, the Esaote 7050 (K944287). The core of the acceptance criteria here is that the new device (7250) is as safe and effective as the predicate device (7050) for its intended uses.
The study proving the device meets these acceptance criteria is a comparison to a legally marketed predicate device. This is a common method for 510(k) clearance, where a new device demonstrates substantial equivalence to an existing device rather than undergoing full clinical trials for novel devices.
Here's the breakdown of the information requested, based on the provided document:
1. Table of Acceptance Criteria and Reported Device Performance
Note: The document does not explicitly state "acceptance criteria" in a quantitative manner (e.g., "sensitivity > X%"). Instead, substantial equivalence relies on demonstrating that the new device is as safe and effective as the predicate device. The "reported device performance" is a comparative list of features and capabilities against the predicate.
| Feature | Acceptance Criteria (based on predicate 7050) | Reported Device Performance (7250) | Device Meets Criteria? |
|---|---|---|---|
| Electrical Safety | EN60601-1 | EN60601-1 | Yes |
| Ultrasound Safety | Track 3 (Acoustic Output Display) | Track 3 (Acoustic Output Display) | Yes |
| Intended Use - Cardiac (Transthoracic) | YES | YES | Yes |
| Intended Use - Cardiac (Transesophageal) | YES (Monoplane) | YES (Multiplane) | Yes (Improved) |
| Intended Use - Vascular | YES | YES | Yes |
| Intended Use - Abdominal | YES | YES | Yes |
| Intended Use - Fetal | YES | YES | Yes |
| Intended Use - Adult Cephalic | YES | YES | Yes |
| Intended Use - Neonatal Cephalic/Small Organ | YES | YES | Yes |
| Intended Use - Endovaginal | YES (Sagittal & Transverse Planes) | YES (Sagittal & Transverse Planes) | Yes |
| Intended Use - Endorectal | YES (Sagittal & Transverse Planes) | YES (Sagittal & Transverse Planes) | Yes |
| Probe Technology - Annual Array | YES | YES | Yes |
| Probe Technology - Electronical Array | YES | YES | Yes |
| Probe Technology - Bi-Scan Probes | NO | YES | Yes (New Feature) |
| Probe Technology - Doppler Probes | YES | YES | Yes |
| Modes of Operation | 2D, M-Mode, PW, CW, CFM, Amplitude Doppler | 2D, M-Mode, PW, CW, CFM, Amplitude Doppler | Yes |
| Imaging Frequencies | 2.5, 3.5, 5.0, 7.5, 10 MHz | 2.5, 3.5, 5.0, 7.5, 10 MHz | Yes |
| CFM/Doppler Frequencies | 2.0, 2.5, 3.3, 5.0, 6.6 MHz | 2.0, 2.5, 3.3, 5.0, 6.6 MHz | Yes |
| Biopsy Guidance - General Purpose (ABS11 & ABS13) | General Purpose | General Purpose | Yes |
| Biopsy Guidance - Transrectal/transvaginal (ABS12) | Transrectal/transvaginal | Transrectal/transvaginal | Yes |
| Biopsy Guidance - Biopsy Line Depth Marker | 1 cm | 1 cm | Yes |
| Biopsy Guidance - Needle Guide Angle | ABS11: 25-45°; ABS12: fixed; ABS13: 30-50° | ABS11: 25-45°; ABS12: fixed; ABS13: 30-50° | Yes |
| Display Type | RGB | SVGA | Yes (Improved/Modern) |
| Digital Archival Capabilities | YES | YES | Yes |
| VCR/Page Printer | YES | YES | Yes |
| M&A Capabilities | Cardiac, Vascular, Fetal and general purpose measurements | Cardiac, Vascular, Fetal and general purpose measurements | Yes |
2. Sample size used for the test set and the data provenance
The document does not detail a specific test set, patient cohort, or data provenance. The substantial equivalence argument relies on a comparison of device specifications and performance parameters rather than human clinical study data in this context. The included "Intended Use" forms for various transducers list "N" for new indications and "P" for previously cleared indications (referring to the predicate device, AU3 unit K944287, or K953716 for TRT12). This indicates that for "P" indications, the performance is considered similar to the predicate. For "N" indications, it implies the new device has been validated for these uses, but the document doesn't provide details on the validation data.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts
Not applicable. This is not a study involving expert readers establishing ground truth for image interpretation.
4. Adjudication method for the test set
Not applicable. No test set requiring adjudication is described.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
Not applicable. The document is for an ultrasound imaging system from 1998, predating the widespread use of AI in medical imaging in the context of regulatory submissions. There is no mention of AI assistance or MRMC studies.
6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done
Not applicable, as this is an ultrasound imaging system and not an AI algorithm.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)
Not explicitly described in terms of a study with ground truth. The "ground truth" for demonstrating safety and effectiveness in this context is the predicate device's established performance and the industry standards for ultrasound systems (e.g., EN60601-1 for electrical safety, Track 3 for acoustic output display). For "new indications" ("N" in the transducer tables), the performance would have been verified through engineering and possibly limited clinical testing, but specifics are not in this summary document.
8. The sample size for the training set
Not applicable. This is not an AI/machine learning device requiring a training set.
9. How the ground truth for the training set was established
Not applicable.
{0}------------------------------------------------
892.1550
892.1560
OCT 6 1998
Safety and Effectiveness Summary 7250 Ultrasound Imaging System Biosound Esaote
Safety and Effectiveness Summary
The following safety and effectiveness summary has been prepared pursuant to requirement for 510(k) summaries specified in 21CFR 807.92(a).
807.92(a)(1)
Submitter Information
Colleen Hittle, Official Correspondent 8000 Castleway Drive Indianapolis, IN 46250 (317) 849-1916 Phone: (317) 577-9070 Facsimile:
Colleen Hittle Contact Person:
Date: July 2, 1998
807.92(a)(2)
7250 Ultrasound Imaging System Trade Name: Ultrasound Imaging System Common Name: Classification Name(s): Ultrasonic pulsed doppler imaging system Ultrasonic pulsed echo imaging system
90IYN 90IYO
7050 (AU3)
Classification Number:
807.92(a)(3)
Predicate Device(s)
Esaote
Additional Substantial Equivalence Information is provided in the following substantial Equivalence Comparison Table.
{1}------------------------------------------------
Safety and Effectiveness Summary 7250 Ultrasound Imaging System Biosound Esaote
807.92(a)(4)
Device Description
ESAOTE's Mod. 7250 is a compact ultrasound system used to perform non-invasive diagnostic general ultrasound studies. Its primary modes of operation are the following: B-Mode, M-Mode, Doppler, Color Flow Mapping and Amplitude Doppler, The MOD.7250 can be equipped with an LCD Color Display (Portable Configuration) or with a 15" Color Monitor and a cart (Mainframe Configuration). The full alphanumeric keyboard allows complete on-screen data entry of patient information and on-screen annotations.
The MOD. 7250 can drive annular array, phased, convex and linear array probes. In addition. Mod.7250 is equipped with a volumetric scan converter and the ability to control simultaneously two independent scan planes. This technological characteristic allows to manage Bi-Scan Probes, to obtain volumetric datasets; these datasets can then be used to display "omni-directional" 2D images (anyplane sectioning) as well as multiple parallel equidistant sections (paraplane sectioning). This Bi-Scan approach is ideal for volume computations through the Simoson rule: specifically, it can be used to measure volumes of irregular structures since it does not reguire a geometrical assumption.
The MOD.7250 is designed for ease of use. The user interface allows the operator to perform an examination quickly and efficiently. Clearly labeled mode selection keys are easily accessed, and the system's "pop-up" menus allow the operator to change parameters with ease. The user may also access special function menus and perform calculations with a minimal number of key strokes. The MOD.7250 offers a vast selection of calculations and measurements which can be performed quickly and easily. The MOD.7250 is equipped with a 3.5" floppy disk drive to simplify software modifications and provides fast, cost effective system upgrades. This drive (or an optional Optical Disk Drive) can also be used for image storage. Moreover, this unit can store data directly to a Personal Computer via a LAN (Network) port. In addition, MOD.7250 can be equipped with recording devices, including a S-VHS video recorder and a black-and-white or color page printer, which are controlled through
807.92(a)(5)
the keyboard.
Intended Use(s)
ESAOTE's Mod. 7250 is a compact ultrasound system used to perform non-invasive diagnostic general ultrasound studies.
{2}------------------------------------------------
K982444 P3 of 3
Safety and Effectiveness Summary 7250 Ultrasound Imaging System Biosound Esaote
| Comparison Chart for Substantial Equivalence | ||
|---|---|---|
| 7250 | 7050 | |
| Electrical Safety | EN60601-1 | EN60601-1 |
| Ultrasound Safety | Track 3 (Acoustic Output Display) | Track 3 (Acoustic Output Display) |
| Intended Use | ||
| • Cardiac (Transthoracic) | YES | YES |
| • Cardiac (Transesophageal) | YES (Multiplane) | YES (Monoplane) |
| • Vascular | YES | YES |
| • Abdominal | YES | YES |
| • Fetal | YES | YES |
| • Adult Cephalic | YES | YES |
| • Neonatal Cephalic/Small organ | YES | YES |
| • Endovaginal | YES (Sagittal & Transverse Planes) | YES (Sagittal & Transverse Planes) |
| • Endorectal | YES (Sagittal & Transverse Planes | YES (Sagittal & Transverse Planes |
| Probe Technology | ||
| • Annual Array | YES | YES |
| • Electronical Array | YES | YES |
| • Bi-Scan Probes | YES | NO |
| • Doppler Probes | YES | YES |
| Modes of operation | 2D, M-Mode, PW, CW, CFM, Amplitude Doppler | 2D, M-Mode, PW, CW, CFM, Amplitude Doppler |
| Imaging Frequencies | 2.5, 3.5, 5.0, 7.5, 10 MHz | 2.5, 3.5, 5.0, 7.5, 10 MHz |
| CFM/Doppler Frequencies | 2.0, 2.5, 3.3, 5.0, 6.6 MHz | 2.0, 2.5, 3.3, 5.0, 6.6 MHz |
| Biopsy Guidance | YES | YES |
| • ABS11 & ABS13 use | General Purpose | General Purpose |
| • ABS12 use | Transrectal/transvaginal | Transrectal/transvaginal |
| • Biopsy Line Depth marker | 1 cm | 1 cm |
| • Needle guide angle | ABS11: 25-45°ABS12: fixedABS13: 30-50° | ABS11: 25-45°ABS12: fixedABS13: 30-50° |
| Display Type | SVGA | RGB |
| Digital Archival Capabilities | YES | YES |
| VCR/Page Printer | YES | YES |
| M&A Capabilities | Cardiac, Vascular, Fetal and general purpose measurements | Cardiac, Vascular, Fetal and general purpose measurements |
{3}------------------------------------------------
Public Health Service
Image /page/3/Picture/2 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized image of an eagle or bird with three wing-like shapes. The bird is positioned in the center of a circular border. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged around the upper portion of the circle.
OCT ୧ 1098
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Colleen Hittle Official Correspondent Biosound Esaote 8000 Castleway Drive Indianapolis, IN 46250
Re: K982444 7250 Ultrasound Imaging System Regulatory Class: II Product Code: 90 IYO/21 CFR 892.1560 Dated: July 2, 1998 Received: July 14, 1998
Dear Ms. Hittle:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
This determination of substantial equivalence applies to the following transducers intended for use with the Mod. 7250, as described in your premarket notification:
Transducer Model Number
PA020 CA11 7510 AA-C LA13 BLA023 5 MHz TEE TRT12
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval) it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General (GMP) regulation (21 CFR Part 820) and that, through periodic QS inspections, the FDA will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, the Food and Drug Administration (FDA) may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification does not affect any obligation you may have under sections 531 and 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
{4}------------------------------------------------
Page 2 - Colleen Hittle
Please be advised that the determination above is based on the fact that no medical devices have been demonstrated to be safe and effective for in vitro fertilization or percutaneous umbilical blood sampling, nor have any devices been marketed for these uses in interstate commerce prior to May 28, 1976, or reclassified into class I (General Controls) or class II (Special Controls). FDA considers devices specifically intended for in vitro fertilization and percutaneous umbilical blood sampling to be investigational, and subject to the provision of the investigational device exemptions (IDE) regulations, 21 Therefore, your product labeling must be consistent with FDA's CFR, Part 812. position on this use.
This determination of substantial equivalence is granted on the condition that prior to shipping the first device, you submit a postclearance special report. This report should contain complete information, including acoustic output measurements based on production line devices, requested in Appendix G, (enclosed) of the Center's September 30, 1997 "Information for Manufacturers Seeking Marketing Clearance of Diagnostic Ultrasound Systems and Transducers." If the special report is incomplete or contains unacceptable values (e.g., acoustic output greater than approved levels), then the 510(k) clearance may not apply to the production units which as a result may be considered adulterated or misbranded.
The special report should reference the manufacturer's 510(k) number. It should be clearly and prominently marked "ADD-TO-FILE" and should be submitted in duplicate to:
Food and Drug Administration Center for Devices and Radiological Health Document Mail Center (HFZ-401) 9200 Corporate Boulevard Rockville, Maryland 20850
This letter will allow you to begin marketing your device as described in your The FDA finding of substantial equivalence of your ... . premarket notification. device to a legally marketed predicate device results in a classification for your device and thus permits your device to proceed to market.
If you desire specific advice for your device on our labeling regulation (21 ... CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4591. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97) . . Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its tollfree number (800) 638-2041 or at (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".
{5}------------------------------------------------
Page 3 - Colleen Hittle
If you have any questions regarding the content of this letter, please contact Paul Gammell, Ph.D. at (301) 594-1212.
Sincerely yours,
David A. Szymon
for Lillian Yin, Ph.D.
Director, Division of Reproductive, Abdominal, Ear, Nose and Throat, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosures
{6}------------------------------------------------
Mod.7250
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Mode of Operation | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Clinical Application | A | B | M | PWD | CWD | ColorDopplerCFM | AmplitudeDopplerPD | ColorVelocityImaging | Combined(specify) | Other (specify) | |
| Ophthalmic | |||||||||||
| Fetal | N | N | N | N | N | Seecomments | |||||
| Abdominal | N | N | N | N | N | Seecomments | |||||
| Intraoperative (specify) | |||||||||||
| Intraoperative Neurological | |||||||||||
| Pediatric | N | N | N | N | N | N | Seecomments | ||||
| Small Organ (specify) [1] | N | N | N | N | N | N | Seecomments | ||||
| Neonatal Cephalic | N | N | N | N | N | N | Seecomments | ||||
| Adult Cephalic | N | N | N | N | N | N | Seecomments | ||||
| Cardiac | N | N | N | N | N | N | Seecomments | ||||
| Transesophageal | N | N | N | N | N | N | Seecomments | ||||
| Transrectal | N | N | N | N | N | Seecomments | |||||
| Transvaqinal | N | N | N | N | N | Seecomments | |||||
| Transurethral | |||||||||||
| Intravascular | |||||||||||
| Peripheral Vascular | N | N | N | N | N | N | Seecomments | N[2] | |||
| Laparoscopic | |||||||||||
| Musculo-skeletal | |||||||||||
| Conventional | |||||||||||
| Musculoskeletal Superficial | |||||||||||
| Other (specify) | |||||||||||
| Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:Mode of Operation | |||||||||||
| Clinical Application | A | B | M | PWD | CWD | ColorDopplerCFM | AmplitudeDopplerPD | ColorVelocityImaging | Combined(specify) | Other (specify) | |
| Ophthalmic | |||||||||||
| Fetal | |||||||||||
| Abdominal | |||||||||||
| Intraoperative (specify) | |||||||||||
| Intraoperative Neurological | |||||||||||
| Pediatric | |||||||||||
| Small Organ (specify) | |||||||||||
| Neonatal Cephalic | |||||||||||
| Adult Cephalic | N | N | N | N | N | N | Seecomments | ||||
| Cardiac | N | N | N | N | N | Seecomments | |||||
| Transesophageal | |||||||||||
| Transrectal | |||||||||||
| Transvaginal | |||||||||||
| Transurethral | |||||||||||
| Intravascular | |||||||||||
| Peripheral Vascular | |||||||||||
| Laparoscopic | |||||||||||
| Musculo-skeletal | |||||||||||
| Conventional | |||||||||||
| Musculoskeletal Superficial | |||||||||||
| Other (specify) |
N=new indication; P=previously cleared by FDA; E= added under Appendix E
Additional Comments: [1] Small organs include Thyroid, Breast and Testicles. [2] This unit manages Bi-scan
probes for volumetric acquisitions from which any 2D tomographic image can be displayed.
Applicable combined modes: B+M+PW+CW+CFM+PD
Daniel A. Segarra
(Division Sign-Off)
(PLEASE DO NOT WRITE BELOW THIS LINE. CONTINUE ON ANOTHER PAGE IF sion of Reproductive, Abdominal, ENT, concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use (Per 21 CFR 801.109)
510(k) Number
11
{7}------------------------------------------------
Transducer: PA020
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body or follows:
N=new indication; P=previously cleared by FDA; E= added under Appendix E
Additional Comments: / Applicable combined modes: B+M+PW+CW+CFM+PD
(PLEASE DO NOT WRITE BELOW THIS JINE. CONTINUE ON ANOTHER PAGE IF NEEDED
concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign-Off)
Division of Reproductive, Abdominal, ENT,
and Radiological Devices
510(k) Number K982444
{8}------------------------------------------------
Transducer: CA11
| Clinical Application | A | B | M | PWD | CWD | ColorDopplerCFM | AmplitudeDopplerPD | ColorVelocityImaging | Combined(specify) | Other (specify) |
|---|---|---|---|---|---|---|---|---|---|---|
| Ophthalmic | ||||||||||
| Fetal | P | P | P | P | P | P | Seecomments | |||
| Abdominal | P | P | P | P | P | P | Seecomments | |||
| Intraoperative (specify) | ||||||||||
| Intraoperative Neurological | ||||||||||
| Pediatric | ||||||||||
| Small Organ (specify) | ||||||||||
| Neonatal Cephalic | ||||||||||
| Adult Cephalic | ||||||||||
| Cardiac | ||||||||||
| Transesophageal | ||||||||||
| Transrectal | ||||||||||
| Transvaginal | ||||||||||
| Transurethral | ||||||||||
| Intravascular | ||||||||||
| Peripheral Vascular | ||||||||||
| Laparoscopic | ||||||||||
| Musculo-skeletal | ||||||||||
| Conventional | ||||||||||
| Musculoskeletal Superficial | ||||||||||
| Other (specify): |
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
N=new indication; P=previously cleared by FDA; E= added under Appendix E
Additional Comments: This transducer has been previously cleared by FDA with the AU3 unit (K944287) for uses indicated as "P". Applicable combined modes: B+M+PW+CFM+PD
(PLEASE DO NOT WRITE BELOW THIS LINE, CONTINUE ON ANOTHER PAGE IF NEEDED
concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use (Per 21 CFR 801.109)
David A. Sijim
(Division Sign-Off)
Division of Reproductive, Abdominal, ENT. and Radiological Devices
510(k) Number K482444
{9}------------------------------------------------
K982494
Diagnostic Ultrasound Indications for Use Form
Transducer: 7510 AA-C
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | A | B | M | PWD | CWD | ColorDopplerCFM | AmplitudeDopplerPD | ColorVelocityImaging | Combined(specify) | Other (specify) |
|---|---|---|---|---|---|---|---|---|---|---|
| Ophthalmic | ||||||||||
| Fetal | ||||||||||
| Abdominal | ||||||||||
| Intraoperative (specify) | ||||||||||
| Intraoperative Neurological | ||||||||||
| Pediatric | N | N | N | N | N | N | Seecomments | |||
| Small Organ (specify) [1] | P | P | P | P | P | P | Seecomments | |||
| Neonatal Cephalic | P | P | P | P | P | P | Seecomments | |||
| Adult Cephalic | ||||||||||
| Cardiac | N | N | N | N | N | N | Seecomments | |||
| Transesophageal | ||||||||||
| Transrectal | ||||||||||
| Transvaginal | ||||||||||
| Transurethral | ||||||||||
| Intravascular | ||||||||||
| Peripheral Vascular | P | P | P | P | P | P | Seecomments | |||
| Laparoscopic | ||||||||||
| Musculo-skeletal | ||||||||||
| Conventional | ||||||||||
| Musculoskeletal Superficial | ||||||||||
| Other (specify) |
N=new indication; P=previously cleared by FDA; E= added under Appendix E
Additional Comments: [1] Small organs include Thyroid, Breast and Testicles. This transducer has been previously cleared by FDA with the AU3 unit (K944287). Applicable combined modes: B+M+PW+CFM
(PLEASE DO NOT WRITE BELOW THIS LINE. CONTINUE ON ANOTHER PAGE IF NEEDED
concurrence of CDRH, Office of Device Evaluation (ODE
Prescription Use (Per 21 CFR 801.109)
(Division Sign-Off)
Division of Reproductive, Abdominal, ENT,
and Radiological Devices
510(k) Number K982444.
Warr
{10}------------------------------------------------
Transducer: LA13
| Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Clinical Application | A | B | M | PWD | CWD | ColorDopplerCFM | AmplitudeDopplerPD | ColorVelocityImaging | Combined(specify) | Other (specify) | |
| Ophthalmic | |||||||||||
| Fetal | |||||||||||
| Abdominal | |||||||||||
| Intraoperative (specify) | |||||||||||
| Intraoperative Neurological | |||||||||||
| Pediatric | |||||||||||
| Small Organ (specify) [1] | N | N | N | N | N | N | Seecomments | ||||
| Neonatal Cephalic | |||||||||||
| Adult Cephalic | |||||||||||
| Cardiac | |||||||||||
| Transesophageal | |||||||||||
| Transrectal | |||||||||||
| Transvaginal | |||||||||||
| Transurethral | |||||||||||
| Intravascular | |||||||||||
| Peripheral Vascular | P | P | P | P | P | P | P | Seecomments | |||
| Laparoscopic | |||||||||||
| Musculo-skeletal | |||||||||||
| Conventional | |||||||||||
| Musculoskeletal Superficial | |||||||||||
| Other (specify) |
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as for
N=new indication; P=previously cleared by FDA; E= added under Appendix E
Additional Comments: [1] Small organs include Thyroid, Breast and Testicles. This transducer has been previously
cleared by FDA with the AU3 unit (K944287). Applicable combined modes: B+M+PW+CFM+PD
(PLEASE DO NOT WRITE BELOW THIS LINE. CONTINUE ON ANOTHER PAGE IF NEEDED
concurrence of CDRH, Office of Device Evaluation (ODE)
David A. Lopson
(Division Sign-Off) (Division of Reproductive, Abdominal, ENT, and Radiological Devices 510(k) Number
{11}------------------------------------------------
Transducer: BLA023
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Mode of Operation | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Clinical Application | A | B | M | PWD | CWD | ColorDopplerCFM | AmplitudeDopplerPD | ColorVelocityImaging | Combined(specify) | Other (specify) | |
| Ophthalmic | |||||||||||
| Fetal | |||||||||||
| Abdominal | |||||||||||
| Intraoperative (specify) | |||||||||||
| Intraoperative Neurological | |||||||||||
| Pediatric | |||||||||||
| Small Organ (specify) | |||||||||||
| Neonatal Cephalic | |||||||||||
| Adult Cephalic | |||||||||||
| Cardiac | |||||||||||
| Transesophageal | |||||||||||
| Transrectal | |||||||||||
| Transvaginal | |||||||||||
| Transurethral | |||||||||||
| Intravascular | |||||||||||
| Peripheral Vascular | N | N | N | N | N | Seecomments | N [1] | ||||
| Laparoscopic | |||||||||||
| Musculo-skeletal | |||||||||||
| Conventional | |||||||||||
| Musculoskeletal Superficial | |||||||||||
| Other (specify) |
N=new indication; P=previously cleared by FDA; E= added under Appendix E
Additional Comments: [1]: This probe can be used to acquire volumetric datasets from which any 2D tomographic
plane can be then visualized. Applicable combined modes: B+M+PW+CFM+PD
(PLEASE DO NOT WRITE BELOW THIS LINE. CONTINUE ON ANOTHER PAGE IF NEEDED
concurrence of CDRH, Office of Device Evaluation (ODE)
David C. Severson
(Division Sign-Off) Division of Reproductive, Abdominal, ENT, and Radiological Devices 510(k) Number
{12}------------------------------------------------
Transducer: 5 MHz TEE
| Clinical Application | Mode of Operation | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | B | M | PWD | CWD | ColorDopplerCFM | AmplitudeDopplerPD | ColorVelocityImaging | Combined(specify) | Other (specify) | ||
| Ophthalmic | |||||||||||
| Fetal | |||||||||||
| Abdominal | |||||||||||
| Intraoperative (specify) | |||||||||||
| Intraoperative Neurological | |||||||||||
| Pediatric | |||||||||||
| Small Organ (specify) | |||||||||||
| Neonatal Cephalic | |||||||||||
| Adult Cephalic | |||||||||||
| Cardiac | |||||||||||
| Transesophageal | N | N | N | N | N | Seecomments | |||||
| Transrectal | |||||||||||
| Transvaginal | |||||||||||
| Transurethral | |||||||||||
| Intravascular | |||||||||||
| Peripheral Vascular | |||||||||||
| Laparoscopic | |||||||||||
| Musculo-skeletal | |||||||||||
| Conventional | |||||||||||
| Musculoskeletal Superficial | |||||||||||
| Other (specify) |
: 1 ต
N=new indication; P=previously cleared by FDA; E= added under Appendix E
Additional Comments: / Applicable combined modes: B+M+PW+CW+CFM
(PLEASE DO NOT WRITE BELOW THIS LINE. CONTINUE ON ANOTHER PAGE IF NEEDED
concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use (Per 21 CFR 801.109)
David A. Legerson
(Division Sign-Off) (Division Sign-Off)
Division of Reproductive, Abdominal, ENT, and Radiological Devices
510(k) Number
{13}------------------------------------------------
Transducer: TRT12
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | A | B | M | PWD | CWD | ColorDopplerCFM | AmplitudeDopplerPD | ColorVelocityImaging | Combined(specify) | Other (specify) |
|---|---|---|---|---|---|---|---|---|---|---|
| Ophthalmic | ||||||||||
| Fetal | ||||||||||
| Abdominal | ||||||||||
| Intraoperative (specify) | ||||||||||
| Intraoperative Neurological | ||||||||||
| Pediatric | ||||||||||
| Small Organ (specify) [1] | ||||||||||
| Neonatal Cephalic | ||||||||||
| Adult Cephalic | ||||||||||
| Cardiac | ||||||||||
| Transesophageal | ||||||||||
| Transrectal | P | P | P | P | P | Seecomments | ||||
| Transvaginal | P | P | P | P | P | Seecomments | ||||
| Transurethral | ||||||||||
| Intravascular | ||||||||||
| Peripheral Vascular | ||||||||||
| Laparoscopic | ||||||||||
| Musculo-skeletal | ||||||||||
| Conventional | ||||||||||
| Musculoskeletal Superficial | ||||||||||
| Other (specify) |
N=new indication; P=previously cleared by FDA; E= added under Appendix E
Additional Comments: This transducer has been previously cleared by FDA with the AU3 unit (K953716).
Applicable combined modes: B+M+PW+CFM+PD
(PLEASE DO NOT WRITE BELOW THIS LINE. CONTINUE ON ANOTHER PAGE IF NEEDED
concurrence of CDRH, Office of Device Evaluation (ODE)
David A. Leggett
(Division Sign-Off) Division of Reproductive, Abdominal, ENT, and Radiological Devices
510(k) Number K982444
§ 892.1560 Ultrasonic pulsed echo imaging system.
(a)
Identification. An ultrasonic pulsed echo imaging system is a device intended to project a pulsed sound beam into body tissue to determine the depth or location of the tissue interfaces and to measure the duration of an acoustic pulse from the transmitter to the tissue interface and back to the receiver. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II (special controls). A biopsy needle guide kit intended for use with an ultrasonic pulsed echo imaging system only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.